Incannex Healthcare IXHL
NASDAQ IXHL
$3.57 -0.05 (-1.38%)
At close: Aug 21, 2026 · 4:00 PM EDT

Incannex Healthcare (IXHL) Depreciation & Amortization (CF) (2023 - 2026)

Incannex Healthcare (IXHL) posted Depreciation & Amortization (CF) of $65000.0 for Q1 2026, up 10.17% sequentially from $59000.0 in Q4 2025, and up 1400.0% YoY from $4333.3 in Q1 2025.

Incannex Healthcare (IXHL) Depreciation & Amortization (CF) (2023 - 2026) Analysis & Trends

Incannex Healthcare has reported Depreciation & Amortization (CF) for 4 years, with the latest figure at $65000.0 in Q1 2026.

  • Quarterly Depreciation & Amortization (CF) rose 1400.0% year-over-year to $65000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $251000.0 (up 1.62% YoY) and the FY2025 annual result came in at $246000.0, up 138.83% from the prior year.
  • Depreciation & Amortization (CF) grew to $65000.0 in Q1 2026 per IXHL's latest filing, from $59000.0 in the prior quarter.
  • Over five years, Depreciation & Amortization (CF) peaked at $126000.0 in Q4 2024 and troughed at -$13000.0 in Q1 2023.
  • A 4-year average of $45538.5 and a median of $61000.0 in 2025 frame the typical range for Depreciation & Amortization (CF).
  • The sharpest annual moves came in 2025 and 2026: Depreciation & Amortization (CF) slumped 129.41% in 2025, then jumped 1400.0% in 2026.
  • Over 4 years, Depreciation & Amortization (CF) stood at $12000.0 in 2023, then jumped by 950.0% to $126000.0 in 2024, then tumbled by 53.17% to $59000.0 in 2025, then climbed by 10.17% to $65000.0 in 2026.
  • According to Business Quant data, Depreciation & Amortization (CF) over the past three periods registered $65000.0, $59000.0, and $66000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Depreciation & Amortization (Qtr)
1 Haleon 44.51 Bn 43.55 Bn - -
2 Teva Pharmaceutical Industries 43.52 Bn 39.86 Bn 2.15 Bn 241.00 Mn
3 Zoetis 32.43 Bn 30.75 Bn 1.05 Bn 119.00 Mn
4 Takeda Pharmaceutical 28.63 Bn 22.83 Bn 5.10 Bn 1.02 Bn
5 United Therapeutics 21.87 Bn 19.21 Bn 683.80 Mn 24.20 Mn
6 Viatris 18.98 Bn 18.09 Bn 1.46 Bn 672.30 Mn
7 Neurocrine Biosciences 15.43 Bn 15.04 Bn 935.80 Mn -
8 Elanco Animal Health 12.02 Bn 11.49 Bn 798.00 Mn 171.00 Mn
9 Dr Reddys Laboratories 10.14 Bn 9.98 Bn - -
10 Incannex Healthcare 44.39 Mn 44.39 Mn - 65,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 65,000.00
Mar 31, 2026 65,000.00
Dec 31, 2025 59,000.00
Dec 31, 2025 59,000.00
Sep 30, 2025 66,000.00
Sep 30, 2025 66,000.00
Jun 30, 2025 61,000.00
Jun 30, 2025 61,000.00
Mar 31, 2025 -5,000.00
Mar 31, 2025 -5,000.00
Dec 31, 2024 126,000.00
Dec 31, 2024 126,000.00
Sep 30, 2024 64,000.00
Sep 30, 2024 64,000.00
Jun 30, 2024 62,000.00
Jun 30, 2024 62,000.00
Mar 31, 2024 17,000.00
Mar 31, 2024 17,000.00
Dec 31, 2023 12,000.00
Dec 31, 2023 12,000.00